Anis Barmada

MD/PhD Candidate @Yale | @PDSoros '22 | #Immunology #Genomics #Healthcare #Biotech | Alum @thisisUIC @Gates_Cambridge @SangerInstitute

[Anis Barmada @AnisBarmada]

Shedding light on the drivers of rare myocarditis after mRNA SARS-CoV-2 vaccination. An important step towards fully realizing the tremendous potential of mRNA vaccines.

Our latest paper published today in @SciImmunology. A summary: (1/11)
https://t.co/jzuTBdc8q2

[PD Soros Fellowships @PDSoros]

📣 Paul & Daisy Soros Fellowships for New Americans is in 3rd place and so close to joining the #Webbys Winners Circle. RT + VOTE: https://t.co/yLhwgM5qM7

[Anis Barmada @AnisBarmada]

Thankful for @PDSoros's continued support and excited for what’s next @Forbes, stay tuned!

[PD Soros Fellowships @PDSoros]

Congrats to #PDSoros Fellows @sylvia_bisco (2018 Fellow), @rishirajgoel (2022 Fellow), & @AnisBarmada (2022 Fellow) on being named to the 2025 Forbes 30 Under 30 Science list! #ForbesUnder30

https://t.co/Hq3ZpUYxow

[GAJET List @GAJETList]

The Yale Journal of Biology and Medicine is the 130th #GAJET (Good Academic Journal in Ethical Terms)
CONGRATULATIONS @theYJBM & thank u @YaleMed 4 sponsoring & publishing #DiamondOpenAccess

https://t.co/gxbQbxLXw9

#OpenAccess #PublicationEthics #Ethics @COPE @ICMJE

[Yale J Biol Med @theYJBM]

Mark your calendars for an upcoming colloquium with Dr. Akiko Iwasaki

[Itai Yanai @ItaiYanai]

Doing good science is 90% finding a science buddy to constantly talk to about the project.

[Angelina (Gina) Bortoletto, MD, PhD @GinaBortoletto]

So thrilled to see people happy with @GlassHealthHQ and you are so right…so much effort has gone into this by the most passionate and intelligent group of physicians and engineers I’ve ever met!

[Anis Barmada @AnisBarmada]

@HendersonShalom CONGRATULATIONS @HendersonShalom!! So happy for you!

[Dereck Paul, MD @dereckwpaul]

Artificial intelligence is already transforming the way we practice medicine.

In @GlassHealthHQ's Future of Medicine essay contest and scholarship, medical students are challenged to envision how technology can be leveraged to change healthcare for the better. #MedX #MedTwitter

[Lawrence T Wang @Lawreate7]

Very pleased to share our comprehensive review on monoclonal antibodies against circumsporozoite protein and how this emerging tool might aid global efforts to control malaria, published today in Nature Immunology!

@AzzaIdris_1, we did it! :)

https://t.co/yLtsEH5YP2

[Glass Health @GlassHealthHQ]

We’re thrilled to launch Modes on our Glass AI CDS platform! Our AI responses are now tailored to specific specialties, starting with Internal Medicine and Emergency Medicine. Enhance your differential diagnoses and plans with specialty-aligned outputs at https://t.co/xbCxXTp7Z8.

[Dereck Paul, MD @dereckwpaul]

Today, we're excited to launch IM & EM Modes for our AI-generated DDx & A&P drafts.🥳

With AI responses tailored by specialty, Glass is a more useful clinical assistant than ever before. Try Modes for yourself today at https://t.co/kqEJm6k2Ro!🎊

#MedX #MedTwitter 🩺

[Max Jordan Nguemeni @MaxJordan_N]

Something that validates the Yale system @YaleMed. Giving learners more autonomy makes them more engaged with their learning than using punitive/controlling devices like mandatory attendance counting toward grades.
https://t.co/iXN55zeqOy

[Lawrence T Wang @Lawreate7]

We co-published b2b papers describing >400 human monoclonal antibodies against the malaria blood-stage antigen RH5! These data will guide testing of current RH5-based vaccines in Africa and improvement of future vaccine candidates.

https://t.co/ldnyVG4dPg
https://t.co/1z5dLhIeSp

[Eric Topol @EricTopol]

Celebrating Great Immigrants, Great Americans
Like Jensen Huang, @ylecun, @ashishkjha, @Ilibagiza, Viviana Gradinaru, and so many others who've made vital contributions to the US and beyond
@CarnegieCorp
#HappyFourth

[PD Soros Fellowships @PDSoros]

Immigrants and children of immigrants give back to our country in profound ways, bringing innovation and creativity. Our Fellowship celebrates this profound gift.

If you're a New American in/or pursuing grad school in 2025-2026, apply by 10/31!

https://t.co/W1ck9rlCRy

[Yale J Biol Med @theYJBM]

The YJBM June 2024 issue on Chronic Disease is available on PubMed Central, read here for free: https://t.co/Kx8UIB3bLz Editors-in-Chief: Anis Barmada, Charlotte Godfrey, Samantha Seneviratne, and Morgan Vanderwall. Deputy Editors: Noah Yann Lee and Bassel Shanab.

[Simona Cristea @simocristea]

new @ScienceMagazine framework to improve cancer early detection:

two injectable priming agents (nanoparticles & engineered antibodies) temporarily slow down the clearance of circulating tumor DNA from the body, allowing for higher detection sensitivity

https://t.co/YDRYRk7L5a

[PD Soros Fellowships @PDSoros]

An important thread by 2021 #PDSoros Fellow and recent @mit_hst/@harvardmed graduate @JamesADiao:

[Anis Barmada @AnisBarmada]

The future is really here 😳

[Glass Health @GlassHealthHQ]

We’re thrilled to introduce Glass Odyssey! 🎉

Our groundbreaking AI Clinical Decision Support now seamlessly integrates hospital EHRs.

Glass Health users can access our best-in-class clinical decision support through every step of the patient encounter. #AICDS #MedX

[Faisal Mahmood @AI4Pathology]

⚡️🔬📣 Excited to share our new @Nature article building and evaluating PathChat, a multimodal generative AI copilot and chatbot for human pathology. Article: https://t.co/OAIG31ofWJ Open Access Link:
https://t.co/tvw6W6qmT9

We leverage our previous success in building foundation models for computational pathology such as UNI / CONCH and combine it with the advancements of large vision language models and generative AI to enable PathChat to answer diverse pathology-related queries. We assessed PathChat using both multiple choice diagnostic questions and open-ended questions.

Congratulations to @MYLu97 @chenbowen118 @DFKW_MD @richardjchen and everyone else who contributed to this work.
Also see blog post from @MYLu97 about this work: https://t.co/exjpKMnrQp , also teasing the development and preview of PathChat 2, a successor to PathChat 1 bringing new capabilities and substantially improved performance to the state-of-the-art.